The fate of (-)1-(benzofuran-2-yl)-2-propylaminopentane · HCl, (-)-BPAP, in rats, a potent enhancer of the impulse-evoked release of catecholamines and serotonin in the brain

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 27, Issue 3, 2002, Pages 157-161

  Magyar, Kálmán ^a   Lengyel, Joseph ^a   Bolehovszky, Andrea ^a   Knoll, Bertha ^a   Miklya, Iidikó ^a   Knoll, Joseph ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

( ) 1 (benzofuran 2 yl) 2 propylaminopentane HCl, ( ) BPAP ; ( )BPAP 14C levels in brain regions; Plasma and tissue levels of ( )BPAP 14C; Urinary and faecal excretion of ( )BPAP 14C

Indexed keywords

1 (BENZOFURAN 2 YL) 2 PROPYLAMINOPENTANE; CATECHOLAMINE; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE RELEASE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG FECES LEVEL; DRUG PENETRATION; DRUG STRUCTURE; DRUG TISSUE LEVEL; DRUG URINE LEVEL; ENTEROHEPATIC CIRCULATION; EVOKED RESPONSE; ISOTOPE LABELING; LIQUID SCINTILLATION COUNTING; MALE; NONHUMAN; RAT; SEROTONIN RELEASE; THIN LAYER CHROMATOGRAPHY;

EID: 0036655697     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190451     Document Type: Article

References (9)

1. Knoll J., Miklya I., Knoll B., Markó R., Kelemen K. (1996): (-)Deprenyl and (-)1-phenyl-2-propylaminopentane, [(-)PPAP], act primarily as potent stimulants of action potential-transmitter release coupling in the catecholaminergic neurones. Life Sci., 58, 817-827.
2. Knoll J., Miklya I., Knoll B., Markó R., Rácz D. (1996): Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain. Life Sci., 58, 2101-2114.
3. Knoll J. (2000): Outlines of a drug strategy to slow brain aging. Neuropsychopharmacologia Hungarica, 2, 151-170.
4. Knoll J. (1998): (-)-Deprenyl (Selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain. Pharmacol. Toxicol., 82, 57-66.
5. South J. (2001): Deprenyl: the anti-aging psychoenergizer. Anti-Aging Bulletin, 4, 4-19.
6. Knoll J. (2001): Antiaging compounds: (-)deprenyl (Selegiline) and (-)1-(benzofuran-2-yl)-2 propylaminopentane, [(-)BPAP], a selective, highly potent enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain. CNS Drug Reviews, 7, 317-345.
7. Knoll J., Yoneda F., Knoll B., Ohde H., Miklya I. (1999): (-)1-(Benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain. Br. J. Pharm., 128, 1723-1732.
8. Yoneda F., Moto M., Sakae M., Ohde H., Knoll B., Miklya I., Knoll J. (2001): Structure-activity studies leading to (-)-1 -(benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP, a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain. Bioorg, Med. Chem., 9, 1197-1212.
9. Oka T., Yasusa T., Ando T., Watanabe M., Yoneda F., Ishida T., Knoll J. (2001): Enantioselective synthesis and absolute configuration of (-)-1-(benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP, a highly potent and selective catecholaminergic activity enhancer. Bioorg, Med. Chem., 9, 1213-1219.